Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 865623 | ISIN: NO0003921009 | Ticker-Symbol: NK1A
Tradegate
21.01.25
14:55 Uhr
1,069 Euro
-0,008
-0,74 %
Branche
Öl/Gas
Aktienmarkt
Sonstige
1-Jahres-Chart
DNO ASA Chart 1 Jahr
5-Tage-Chart
DNO ASA 5-Tage-Chart
RealtimeGeldBriefZeit
1,0711,07921.01.
1,0711,07921.01.
GlobeNewswire (Europe)
127 Leser
Artikel bewerten:
(0)

DNO ASA: DNO Strikes Oil in New Play Offshore Norway

Finanznachrichten News

Oslo, 2 December 2024 - DNO ASA, the Norwegian oil and gas operator, today announced an oil discovery in license PL1086 in which the Company holds a 50 percent operated interest with the balance held by partners Aker BP ASA (20 percent), Petoro AS (20 percent) and Source Energy AS (10 percent).

Light oil was discovered in Palaeocene sandstones of good reservoir quality with preliminary estimates of gross recoverable resources in the range of 27-57 million barrels of oil equivalent (MMboe) on a P90-P10 basis, with a mean of 41 MMboe.

As this is the first time moveable oil has been encountered in the Borr unit of the Våle Formation in the Norwegian sector, the discovery is considered a play opener. The well had two exploration targets, a deeper prospect (Falstaff) where no reservoir was encountered and a shallower prospect (Othello) where a 16-meter net oil bearing reservoir was encountered. This discovery was subsequently confirmed in a sidetrack.

The Othello discovery marks the second new play DNO, as operator, has proven recently in Norway, following last year's Norma discovery (30 percent and operator). Remarkably, Othello has discovered oil east in the basin where migration risk was commonly thought to be too high. In recent years, the industry has shown little exploration interest in this area, which has been disparagingly called "the dry belt".

Together with its partners, DNO is already considering tying back the discovery to existing infrastructure, with the ConocoPhillips Ekofisk hub some 40 kilometers to the west and the Valhall hub operated by Aker BP some 55 kilometers to the southwest.

"DNO has become a North Sea playmaker," said Executive Chairman Bijan Mossavar-Rahmani. "We have proven persistent, purposeful and pertinacious and these qualities pay in exploration. In addition to our ongoing exploration campaign, we will focus on other identified, and now derisked by Othello, prospects in the area," he added.

Meanwhile, the licensees of nearby PL1085, comprising DNO (25 percent), Aker BP (55 percent and operator) and Petoro (20 percent), are considering developing the 2022 Overly discovery in the permit as a tieback to Aker BP's Valhall hub based on recently completed studies leading to increased estimates of recoverable resources. Overly lies 10 kilometers north of Valhall.

The PL1086 well and the sidetrack were drilled by the Noble Invincible jackup which will now move to drill a production well on the nearby Tambar East oilfield in which DNO holds a 37.8 percent interest.

Also nearby, the 2026 Sunndal exploration well is planned to be drilled in PL1171 by DNO (50 percent) and Aker BP (50 percent and operator).

-

For further information, please contact:
Media: media@dno.no
Investors: investor.relations@dno.no

-

DNO ASA is a Norwegian oil and gas operator active in the Middle East, the North Sea and West Africa. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Côte d'Ivoire, Netherlands and Yemen.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.